Symbiotec Pharmalab Ltd. ಕಂಪನಿ ಇತಿಹಾಸ ಮತ್ತು ವಾರ್ಷಿಕ ಬೆಳವಣಿಗೆ ವಿವರ

Our Company wasincorporated as‘Symbiotec Pharmalab Private Limited’ as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated September 20, 2002, issued by the Registrar of Companies, Madhya Pradesh and Chhattisgarh. Subsequently, in the interest of business expansion and issuing fresh shares to the public to meet requirements of funds for a project being undertaken by the Company which would have resulted into increase in the members of the Company beyond fifty, our Company was converted from a private limited company to a public limited company, pursuant to the Board resolution dated September 22, 2005 and a resolution passed in the extraordinary general meeting of our Shareholders held on October 18, 2005 and the name of our Company was changed to Symbiotec Pharmalab Limited, and a certificate of change of name dated October 27, 2005 was issued to our Company by the Registrar of Companies, Madhya Pradesh & Chhattisgarh. Further, considering the absence of public involvement in the shareholding pattern and the management of the Company, our Company was converted to a private limited company pursuant to the Board resolution dated April 23, 2014 and a resolution passed in the extraordinary general meeting of our Shareholders on May 22, 2014 and the name of our Company was changed to Symbiotec Pharmalab Private Limited and a certificate of incorporation, consequent upon conversion to a private limited company, was issued by the RoC on July 25, 2014. Thereafter, as part of the Company’s strategic vision for future growth and expansion, our Company was converted into a public company, pursuant to the Board resolution dated September 11, 2025, and a special resolution dated September 12, 2025, passed in the extraordinary general meeting of our Shareholders. Consequently, the name of our Company was changed to Symbiotec Pharmalab Limited and a fresh certificate of incorporation dated September 26, 2025, consequent upon conversion to a public company, was issued by the Registrar of Companies, Central Processing Centre.

2004

- Commenced production of APIs at the Rau Facility

2007

- Investment by late Rakesh Jhunjhunwala in our Company

2009

- Received a letter stating that the Rau Facility meets an acceptable state of compliance with cGMP by U.S. FDA

2010

- Commenced production of APIs including hormone synthesis at the Pithampur Facility

- Commissioned a 5 KL biotech plant at the Pithampur Facility

- Investment by Franklin Templeton Asset Management (India) Private Limited in our Company

2012

- Received a letter stating that the Pithampur Facility meets an acceptable state of compliance with the cGMP from the U.S. FDA

2013

- Investment by Actis Medal Sports Limited in our Company

- Commissioned a 35 KL fermentation project at the Pithampur Facility

2018

- Investment by India Business Excellence Fund- III and Rosewood Investments in our Company

2021

- Expansion of a sterile plant at the Rau Facility

2023

- Launched classical fermentation-based APIs at the Pithampur Facility

2025

- Commissioned a complex injectables facility at the Mhow Facility

- Commissioned a 400 KL biomanufacturing facility at the Ujjain Facility